Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07866833 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Dysfunction of Respiratory Enzymes in Adults With Mental Illness (DREAM)

Study acronym: DREAM
StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study tested whether intravenous methylene blue changes brain activity during a working-memory task differently in adults with schizophrenia taking stable antipsychotic medication and healthy volunteers. Each participant received methylene blue and a placebo solution with no methylene blue at separate visits and completed the task during functional magnetic resonance imaging (fMRI)
Trial Details
NCT Number NCT07866833
Lead Sponsor King's College London
Collaborators: Imperial College London
Conditions
(from sponsor)		 Schizophrenia and Other Psychotic Disorders, Healthy Adult
Related terms Schizophrenia
Enrollment 53 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov